<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7214347\results\search\disease\results.xml">
  <result pre=": bold;} span.year {font-family : courier ; font-style : italic;}" exact="Diabetes" post="Res Clin PractDiabetes Res. Clin. PractDiabetes Research and Clinical"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="as the COVID-19 resource centre remains active. Keywords COVID-19 Italy" exact="Diabetes mellitus" post="Comorbidities Chronically ill patients Between the end of the"/>
  <result pre="of 2019 and the beginning of 2020 caused by SARS-CoV-2" exact="virus infection," post="starting in Wuhan, China, and spreading throughout the world"/>
  <result pre="the world thereafter [1], [2]. Event sequence The first COVID-19" exact="infection" post="case, referring to a 55-year-old man in Hubei province,"/>
  <result pre="Case 1 was a 38-year old man from Codogno having" exact="respiratory" post="tract infection signs. His wife and a close friend"/>
  <result pre="was a 38-year old man from Codogno having respiratory tract" exact="infection" post="signs. His wife and a close friend were also"/>
  <result pre="Rome (1,352,000 versus 2,873,000), Milan has suffered from a five-fold" exact="infection" post="rate so far (see Table 2 ). Table 1"/>
  <result pre="Sondrio 937 Varese 2,106 other / to be verified 1,374" exact="TOTAL" post="65,381 LAZIO TOWN CASES Rome 4,018 Frosinone 505 Rieti"/>
  <result pre="Viterbo 349 Latina 436 other / to be verified 80" exact="TOTAL" post="5,668 Table 2 Demographics from Lombardy and Lazio. (Source:"/>
  <result pre="the Spallanzani Hospital, a 40-year-renowned research and care center for" exact="infectious diseases" post="and all their travel-mates and contacts were identified and"/>
  <result pre="and multiple outbreak sites might have favored such a large" exact="infection" post="spreading pattern in Northern Italy. Two more observations might"/>
  <result pre="validation by controlled studies: (i) a large number of treatment-resistant" exact="pneumonia" post="events occurring already in January were reported by GPs"/>
  <result pre="potentially unrecognized carriers responsible for the exponential spreading of coronavirus" exact="infection" post="[15] and (ii) more severe fine dust pollution and"/>
  <result pre="to the rest of Italy, as also apparent from European" exact="Space" post="Agency reports [17], [18]. Finally, as far as type"/>
  <result pre="European Space Agency reports [17], [18]. Finally, as far as" exact="type 2" post="diabetes mellitus (T2DM) is concerned, we now have to"/>
  <result pre="Agency reports [17], [18]. Finally, as far as type 2" exact="diabetes mellitus" post="(T2DM) is concerned, we now have to underline that,"/>
  <result pre="by Chinese scientists directly involved in the management of COVID-19" exact="infection" post="[20], [21], the disease is extremely frequent and associates"/>
  <result pre="involved in the management of COVID-19 infection [20], [21], the" exact="disease" post="is extremely frequent and associates with a higher mortality"/>
  <result pre="Table 3 Absolute and relative prevalence of most common pre-existing" exact="cardiovascular" post="and metabolic comorbidities as retrieved from available charts concerning"/>
  <result pre="charts concerning 1,890 COVID-19-positive people dying in Italian hospitals. [21]." exact="Disease" post="N % Ischemic heart disease 518 27.4 Atrial Fibrillation"/>
  <result pre="people dying in Italian hospitals. [21]. Disease N % Ischemic" exact="heart" post="disease 518 27.4 Atrial Fibrillation 411 21.7 Heart failure"/>
  <result pre="dying in Italian hospitals. [21]. Disease N % Ischemic heart" exact="disease" post="518 27.4 Atrial Fibrillation 411 21.7 Heart failure 298"/>
  <result pre="hospitals. [21]. Disease N % Ischemic heart disease 518 27.4" exact="Atrial Fibrillation" post="411 21.7 Heart failure 298 15.8 Stroke 206 10.9"/>
  <result pre="[21]. Disease N % Ischemic heart disease 518 27.4 Atrial" exact="Fibrillation" post="411 21.7 Heart failure 298 15.8 Stroke 206 10.9"/>
  <result pre="% Ischemic heart disease 518 27.4 Atrial Fibrillation 411 21.7" exact="Heart" post="failure 298 15.8 Stroke 206 10.9 Hypertension 1,317 69.7"/>
  <result pre="Fibrillation 411 21.7 Heart failure 298 15.8 Stroke 206 10.9" exact="Hypertension" post="1,317 69.7 Type 2-Diabetes 603 31.9 Obesity 230 12.2"/>
  <result pre="Stroke 206 10.9 Hypertension 1,317 69.7 Type 2-Diabetes 603 31.9" exact="Obesity" post="230 12.2 Diabetes and uncontrolled glycaemia had already been"/>
  <result pre="Hypertension 1,317 69.7 Type 2-Diabetes 603 31.9 Obesity 230 12.2" exact="Diabetes" post="and uncontrolled glycaemia had already been reported as significant"/>
  <result pre="69.7 Type 2-Diabetes 603 31.9 Obesity 230 12.2 Diabetes and" exact="uncontrolled" post="glycaemia had already been reported as significant predictors of"/>
  <result pre="influenza A (H1N1) [23], SARS-CoV [24] and MERS-CoV [25]. SARS-CoV-2" exact="Infection" post="in individuals with DM is expected to trigger higher"/>
  <result pre="suffered at least one hypoglycemic event (&amp;lt;3.9Ã‚ mmol/L) [27]. Notoriously," exact="hypoglycemia" post="mobilizes pro-inflammatory monocytes and increases platelet reactivity, thus contributing"/>
  <result pre="monocytes and increases platelet reactivity, thus contributing to a higher" exact="cardiovascular" post="mortality in patients with DM [28]. In addition, hyperglycemia"/>
  <result pre="higher cardiovascular mortality in patients with DM [28]. In addition," exact="hyperglycemia" post="and insulin resistance enhance the build-up of glycosylation end"/>
  <result pre="may in fact contribute to the mechanisms underlying the greater" exact="susceptibility to" post="infections and the worse outcomes thereof observed in patients"/>
  <result pre="fact contribute to the mechanisms underlying the greater susceptibility to" exact="infections" post="and the worse outcomes thereof observed in patients with"/>
  <result pre="patients with DM [30]. Mostly based on in vitro studies," exact="hyperglycemia" post="associates with several immune system defects, including inhibited lymphocyte"/>
  <result pre="and neutrophil functions [30]. In vitro studies have shown that" exact="pulmonary" post="epithelial cells exposure to high glucose concentrations significantly increases"/>
  <result pre="neutrophil functions [30]. In vitro studies have shown that pulmonary" exact="epithelial" post="cells exposure to high glucose concentrations significantly increases influenza"/>
  <result pre="epithelial cells exposure to high glucose concentrations significantly increases influenza" exact="virus infection" post="and replication, pointing to hyperglycemia-enhanced viral replication in vivo[34]."/>
  <result pre="cells exposure to high glucose concentrations significantly increases influenza virus" exact="infection" post="and replication, pointing to hyperglycemia-enhanced viral replication in vivo[34]."/>
  <result pre="significantly increases influenza virus infection and replication, pointing to hyperglycemia-enhanced" exact="viral" post="replication in vivo[34]. In animal models, structural lung changes"/>
  <result pre="augmented vasculature permeability and collapsed alveolar epithelium [35]. Finally, abnormal" exact="delayed-type hypersensitivity" post="reaction and complement activation dysfunction [36] have been reported"/>
  <result pre="vasculature permeability and collapsed alveolar epithelium [35]. Finally, abnormal delayed-type" exact="hypersensitivity" post="reaction and complement activation dysfunction [36] have been reported"/>
  <result pre="people with DM during COVID-19 infection, due to a significantly" exact="lower" post="forced vital capacity (FVC) and forced expiratory volume in"/>
  <result pre="raised glucose levels [37]. So which pathogenetic elements underly higher" exact="susceptibility to" post="COVID-19 disease and mortality rate in people with DM?"/>
  <result pre="[37]. So which pathogenetic elements underly higher susceptibility to COVID-19" exact="disease" post="and mortality rate in people with DM? The virus"/>
  <result pre="with DM [20], [34] who, by definition, face a clear-cut" exact="prothrombotic state" post="[35], further aggravated by chronic low-grade inflammation causing atherosclerosis-related"/>
  <result pre="definition, face a clear-cut prothrombotic state [35], further aggravated by" exact="chronic" post="low-grade inflammation causing atherosclerosis-related endothelial dysfunction and insulin-resistance associated"/>
  <result pre="chronic low-grade inflammation causing atherosclerosis-related endothelial dysfunction and insulin-resistance associated" exact="arterial hypertension" post="[36]. All above-mentioned phenomena are known to become more"/>
  <result pre="low-grade inflammation causing atherosclerosis-related endothelial dysfunction and insulin-resistance associated arterial" exact="hypertension" post="[36]. All above-mentioned phenomena are known to become more"/>
  <result pre="the observation that octogenarian individuals are mostly affected by SARS-CoV-2" exact="disease" post="[19]. With respect to that, an issue deserving special"/>
  <result pre="an issue deserving special attention is the quite similar SASR-CoV-2" exact="infection" post="rate in people without or with DM [25] in"/>
  <result pre="[25] in front of a much greater severity of the" exact="disease" post="as reported by the Italian ISS in the latter."/>
  <result pre="protective. Dipeptidyl-dipeptidase-4 (DPP-4) was shown, in fact, to be the" exact="primary" post="receptor of MERS-CoV [37]: the possibility that DPP-4 also"/>
  <result pre="increase the risk for a more severe expression of SARS-CoV-2" exact="infection" post="in people with diabetes [40]. Corticosteroid utilization also requires"/>
  <result pre="a more severe expression of SARS-CoV-2 infection in people with" exact="diabetes" post="[40]. Corticosteroid utilization also requires special attention with respect"/>
  <result pre="Corticosteroid utilization also requires special attention with respect to COVID-19" exact="disease" post="severity in people with DM [41]. Acute lung damage"/>
  <result pre="respect to COVID-19 disease severity in people with DM [41]." exact="Acute" post="lung damage and acute respiratory distress syndrome (ARDS) are"/>
  <result pre="severity in people with DM [41]. Acute lung damage and" exact="acute" post="respiratory distress syndrome (ARDS) are partly due to the"/>
  <result pre="in people with DM [41]. Acute lung damage and acute" exact="respiratory" post="distress syndrome (ARDS) are partly due to the host"/>
  <result pre="with DM [41]. Acute lung damage and acute respiratory distress" exact="syndrome" post="(ARDS) are partly due to the host immune response"/>
  <result pre="response and corticosteroids were broadly used in SARS-CoV and MERS-CoV" exact="infections" post="[42], [43] due to their ability to suppress histologically"/>
  <result pre="[43] due to their ability to suppress histologically proven virus-dependent" exact="lung inflammation" post="with diffuse alveolar damage [44]. However, they also inhibit"/>
  <result pre="their ability to suppress histologically proven virus-dependent lung inflammation with" exact="diffuse" post="alveolar damage [44]. However, they also inhibit immunity and"/>
  <result pre="little benefit if so ever, have been associated with delayed" exact="viral" post="RNA clearance or increased mortality and rate of complications,"/>
  <result pre="increased mortality and rate of complications, including diabetes, psychosis, and" exact="avascular necrosis" post="[42]. Due to all the above, the interim guidance"/>
  <result pre="interim guidance from the WHO on clinical management of severe" exact="acute" post="respiratory infection advises against the use of corticosteroids upon"/>
  <result pre="guidance from the WHO on clinical management of severe acute" exact="respiratory" post="infection advises against the use of corticosteroids upon suspicion"/>
  <result pre="from the WHO on clinical management of severe acute respiratory" exact="infection" post="advises against the use of corticosteroids upon suspicion of"/>
  <result pre="advises against the use of corticosteroids upon suspicion of SARS-CoV-2" exact="infection" post="outside clinical trials [45], yet corticosteroids were extensively utilized"/>
  <result pre="hospitalized patients [46]. At analysing the growth curve of coronavirus" exact="infection" post="in Italy, the massive referral to the hospitals of"/>
  <result pre="the hospitals of so many people within a very a" exact="short" post="period strikes the eye when compared to the small"/>
  <result pre="health professionals at the start of the epidemic in the" exact="absence of" post="any experience with treating COVID-19 disease, a broader recourse"/>
  <result pre="needed for treatment personalization, the use of corticosteroids is extremely" exact="limited" post="if so ever. This might also help healthcare teams"/>
  <result pre="the ISS, https://www.iss.it/coronavirus) [12]. Fig. 5 Territorial differences in SARS-CoV-2" exact="infection" post="within Italy as of April 16, 2020 (Source: Data"/>
  <result pre="severe COVID-19 disease, shows that a high adherence to the" exact="Mediterranean" post="diet is significantly more frequent among people living in"/>
  <result pre="higher phenolic acid and lignan intake due to a higher" exact="consumption" post="of cereals and legumes and a slightly lower total"/>
  <result pre="a higher consumption of cereals and legumes and a slightly" exact="lower" post="total polyphenol intake as flavonoids and stilbenes due to"/>
  <result pre="higher consumption of cereals and legumes and a slightly lower" exact="total" post="polyphenol intake as flavonoids and stilbenes due to lower"/>
  <result pre="lower total polyphenol intake as flavonoids and stilbenes due to" exact="lower" post="wine consumption [49]. This takes on a particular significance"/>
  <result pre="polyphenol intake as flavonoids and stilbenes due to lower wine" exact="consumption" post="[49]. This takes on a particular significance when comparing"/>
  <result pre="aware that: Ã¢â‚¬Â¢a strikingly different trend was observed for SARS-CoV-2" exact="infection" post="between Northern and Southern Italy; Ã¢â‚¬Â¢strict containment rules are"/>
  <result pre="of polyphenol-derived antioxidants from cereals and legumes typical of the" exact="Mediterranean" post="diet might help to stop SARS-CoV-2 infection from spreading."/>
  <result pre="typical of the Mediterranean diet might help to stop SARS-CoV-2" exact="infection" post="from spreading. To borrow from Plutarch, the conditions described"/>
  <result pre="and especially its Northern part and to somewhat spare the" exact="Central" post="and Southern areas so far, whose ancient Greek culture-derived"/>
  <result pre="might have positively, albeit almost unexplainedly and inadvertently, influenced the" exact="susceptibility to" post="coronavirus infection. Funding The paper was supported by a"/>
  <result pre="aprile 2020. Troppa gente in giro a Milano. https://milano.repubblica.it/cronaca/2020/04/04/news/coronavirus_milano_sala_troppa_gente_in_giro_controlli-253101858/ 15GentileSandroStrolloFeliceCerielloAntonioCOVID-19" exact="infection" post="in Italian people with diabetes: Lessons learned for our"/>
  <result pre="Liang WH, Ou CQ, He JX. Clinical characteristics of coronavirus" exact="disease" post="2019 in China. N Engl J Med. 2020:1Ã¢â‚¬&quot;13. Epub"/>
  <result pre="32109013. 21ShiH.HanX.JiangN.CaoY.AlwalidO.Gu J Radiological findings from 81 patients with COVID-19" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet Infect Dis.2042020425434Epub 2020/02/28"/>
  <result pre="clinical severity. BMC Infect Dis. 2019;19(1). 24YangJ.K.FengY.YuanM.Y.YuanS.Y.FuH.J.WuB.Y.Plasma glucose levels and" exact="diabetes" post="are independent predictors for mortality and morbidity in patients"/>
  <result pre="blood glucose management for the outbreak of 2019 novel coronavirus" exact="disease" post="(COVID-19) is urgently neededDiabetes Res Clin Pract.1622020108118 27ZhouJ.TanJ.Diabetes patients"/>
  <result pre="Thomas MR, Birch L, et al. Effect of Hypoglycemia on" exact="Inflammatory" post="Responses and the Response to Low-Dose Endotoxemia in Humans."/>
  <result pre="Metab. 2019;104(4):1187-99. Epub 2018/09/27. doi: 10.1210/jc.2018-01168. PubMed PMID: 30252067; PubMed" exact="Central" post="PMCID: PMCPMC6391720. 30KnappSylviaDiabetes and Infection: Is There a Link?"/>
  <result pre="R.GuzikTomasz J.TouyzRhian M.Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and" exact="Vascular" post="MechanismsCan J Cardiol345201857558410.1016/j.cjca.2017.12.00529459239 32Geerlings SE, Hoepelman AI. Immune dysfunction"/>
  <result pre="Cardiol345201857558410.1016/j.cjca.2017.12.00529459239 32Geerlings SE, Hoepelman AI. Immune dysfunction in patients with" exact="diabetes mellitus" post="(DM). FEMS Immunol Med Microbiol. 1999;26(3-4):259-65. Epub 1999/11/27. doi:"/>
  <result pre="33Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in" exact="diabetes" post="mellitus: analysis of the factors and mechanisms involved. Relevance"/>
  <result pre="to the increased susceptibility of diabetic patients to specific infections." exact="Diabete" post="Metab. 1992;18(3):187-201. Epub 1992/05/01. PubMed PMID: 1397473. 34KohioHinissan P.AdamsonAmy"/>
  <result pre="control of vacuolar-type ATPase activity: A mechanism to regulate influenza" exact="viral" post="infectionVirology4441-2201330130910.1016/j.virol.2013.06.02623876457 35DunnE.J.GrantP.J.Type 2 diabetes: an atherothrombotic syndromeCurr Mol Med.532005323332Epub"/>
  <result pre="be reconsidered amid COVID-19 pandemic?Diabetes Res Clin Pract163202010814610.1016/j.diabres.2020.108146 40CerielloA.StoianA.P.RizzoM.COVID-19 and" exact="diabetes" post="management: what should be considered?Diabetes Res Clin Pract.163202010815110.1016/j.diabres.2020.108151 41World"/>
  <result pre="Res Clin Pract.163202010815110.1016/j.diabres.2020.108151 41World Health Organization. Clinical management of severe" exact="acute" post="respiratory infection (SARI) when COVID-19 disease is suspected. Interim"/>
  <result pre="Clin Pract.163202010815110.1016/j.diabres.2020.108151 41World Health Organization. Clinical management of severe acute" exact="respiratory" post="infection (SARI) when COVID-19 disease is suspected. Interim guidance,"/>
  <result pre="Pract.163202010815110.1016/j.diabres.2020.108151 41World Health Organization. Clinical management of severe acute respiratory" exact="infection" post="(SARI) when COVID-19 disease is suspected. Interim guidance, 13"/>
  <result pre="Clinical management of severe acute respiratory infection (SARI) when COVID-19" exact="disease" post="is suspected. Interim guidance, 13 March 2020 Geneva2020 [28/03/2020]."/>
  <result pre="G.BouchamaAbderrezakLukeThomasBaillieJ. KennethAl-OmariAwadHajeerAli H.SengaMikikoDenisonMark R.Nguyen-Van-TamJonathan S.ShindoNahokoBerminghamAlisonChappellJames D.Van KerkhoveMaria D.FowlerRobert A.Middle East" exact="Respiratory" post="SyndromeN Engl J Med3766201758459410.1056/NEJMsr140879528177862 44JaberEmamiPasuttoFranco M.MercerJohn R.Jamali Fakhreddin. Inhibition"/>
  <result pre="Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in" exact="cytosolic" post="fraction of liver homogenates from healthy and diabetic ratsLife"/>
  <result pre="insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction" exact="of liver" post="homogenates from healthy and diabetic ratsLife Sci.6451998325335 45Arabi YM,"/>
  <result pre="al. Corticosteroid Therapy for Critically Ill Patients with Middle East" exact="Respiratory" post="Syndrome. Am J Respir Crit Care Med. 2018;197(6):757-67. Epub"/>
  <result pre="29161116. 46Gentile S, Strollo F, Ceriello A. The need for" exact="diabetes" post="care customization in the ICU at the time of"/>
  <result pre="Signorini S, et al.; TOSCA.IT Study Group. Impact of a" exact="Mediterranean" post="Dietary Pattern and Its Components on Cardiovascular Risk Factors,"/>
  <result pre="Risk Factors, Glucose Control, and Body Weight in People with" exact="Type 2" post="Diabetes: A Real-Life Study. Nutrients. 2018 Aug 10;10(8). pii:"/>
  <result pre="intake and major food sources of polyphenols in people with" exact="type 2" post="diabetes: The TOSCA.IT Study. Eur J Nutr. 2018 Mar;57(2):679-688."/>
 </snippets>
</snippetsTree>
